12.2.2018 | Ajankohtaista
Faculty Position in Pharmacogenetics / Pharmacogenomics of Alcohol and Substance Use Disorders
University of Kentucky
College of Pharmacy
Assistant/Associate/Full Professor, 12-months, Regular Title Series
The College of Pharmacy at the University of Kentucky invites applications for a qualified pharmacogenetic / pharmacogenomic scientist at the rank of Assistant, Associate or Full Professor to coordinate and integrate research in the area of alcohol and substance use disorders (ASUD). The institution has identified faculty recruitment priorities that reflect health care disparities in the state of Kentucky particularly alcohol and substance use disorders. Other health care disparities that disproportionately affect the citizens of Kentucky include cancer, obesity, and cardiovascular disease. The College has a long history of excellence in basic, clinical and applied sciences research across its departments of Pharmaceutical Sciences and Pharmacy Practice and Science. These efforts span the translational research continuum, focusing on health issues that impact patients at the local and national level. The College is one of six colleges within the academic medical center of the University with many opportunities for interdisciplinary collaborative research. The University boasts three renowned research centers with specific focus in the ASUDs. The College seeks to grow the research enterprise by strategically investing in the ASUD focus area.
Previous work has established that ASUDs are highly heritable, developmental disorders, and genes and gene variants have been identified that may impact fundamental biological mechanisms underpinning these disorders. We seek to establish an open rank position focused on the genomics/genetics/epigenetics of ASUD to support collaborative, unifying research that integrates into practice-based research ultimately improving human health by predicting risk, developmental progression, persistence, cessation, and relapse, as well as tailoring effective therapeutics using genomic approaches.
Qualified candidates will have a PhD, MD, or PharmD in a related field; a developing or sustained record of using genomic methods designed to achieve the overall objectives in the prevention and treatment of ASUD; a developing or sustained record of scholarly achievement as appropriate based on rank; and a strong track record of acquiring extramural research funding or potential to acquire extramural funding as appropriate based on rank. Additional requirements include excellent interpersonal skills; excellent oral and written communication skills; strength in team building; a commitment to development of and scholarly participation in genomic research programs at the College of Pharmacy and the University of Kentucky, and a collaborative orientation toward University, community and state activities that enhance the health of the citizens of Kentucky.
Application review will begin March 1 and continue until the position is filled. The University of Kentucky is committed to a diverse and inclusive workforce by ensuring all our students, faculty, and staff work in an environment of openness and acceptance. We strive to foster a community where people of all backgrounds, identities, and perspectives can feel secure and welcome. We also value the well-being of each of our employees and are dedicated to creating a healthy place to work, learn and live. In the interest of maintaining a safe and healthy environment for our students, employees, patients and visitors the University of Kentucky is a Tobacco & Drug Free campus. As an Equal Opportunity Employer, we strongly encourage veterans, individuals with disabilities, women, and all minorities to consider our employment opportunities. Any candidate offered a position may be required to pass pre-employment screenings as mandated by University of Kentucky Human Resources. These screenings may include a national background check and/or drug screen.
7.2.2018 | Ajankohtaista
Tampereella BioMediTech-instituutissa Aikuisen kantasolujen tutkimusryhmässä on solu-ja kudosteknologian alan gradupaikka tarjolla opintojen loppumetreillä olevalle opiskelijalle. Aikuisen kantasolujen tutkimusryhmä tutkii muun muassa mesenkymaalisten kantasolujen käyttöä luun kudosteknologisissa sovelluksissa. http://www.biomeditech.fi/research/adult-stem-cell-group/
Kyseisessä graduprojektissa tutkitaan rasvan kantasolujen luuerilaistuksen taustalla olevia molekulaarisia mekanismeja geeni-ja proteiinitasolla. Projektissa kasvatetaan ja erilaistetaan kantasoluja ja selvitetään erilaistumiselle keskeisiä signalointireittejä. Näiden mekanismien ymmärtäminen on edellytys kudosteknologisten menetelmien kehitykselle tulevaisuudessa. Projekti koostuu 5-6 kk kestävästä kokeellisesta osuudesta ja 2-3kk kirjallisen raportin (Pro Gradu-tutkielma) laatimisesta (Pro Gradu tutkielman laajuutta, 40 op, vastaava työpanos).
Työn aloitusaika on joustava. Gradun ohjaajina toimivat tohtoriopiskelija Laura Hyväri ja tutkijatohtori Sari Vanhatupa. Työn alussa saat perusteellisen ohjauksen soluviljelyyn ja tarvittaviin analyysimenetelmiin sekä ohjausta ja tukea kirjallisen osion tekemiseen. Työskentely on pääosin itsenäistä, joten tarvitset myös itsenäistä otetta tutkimuksen toteutukseen.
Tiedustelut: Laura Hyväri; laura.hyvari@uta.fi & Sari Vanhatupa; sari.vanhatupa@uta.fi
5.2.2018 | Ajankohtaista
|
Postdoctoral Researcher
|
The University of Eastern Finland, UEF, is one of the largest multidisciplinary universities in Finland. We offer education in nearly one hundred major subjects, and are home to approximately 15,000 students and 2,500 members of staff. From 1 August 2018 onwards, we’ll be operating on two campuses, in Joensuu and Kuopio. In international rankings, we are ranked among the leading universities in the world.
The Faculty of Health Sciences operates at the Kuopio Campus of the University of Eastern Finland. The Faculty offers education in medicine, dentistry, nutrition and pharmacy, as well as in some other central fields of the health care sector. The Faculty is research-intensive, and its internationally recognised research activities are closely linked to the strategic research areas of the University. There are approximately 2 500 degree students and about 450 PhD students in the Faculty. The faculty has 680 staff members. http://www.uef.fi/en/ttdk/etusivu
We are now inviting applications for
Postdoctoral Researcher position, A.I. Virtanen Institute for Molecular Sciences, Kuopio Campus
The position is offered by the University of Eastern Finland and relates to a project that is sponsored by a pharmaceutical company. The chosen candidate will be based in the group of Associate Professor Tarja Malm (https://www.uef.fi/en/web/aivi/tarja-malm-group) and the project will be carried out in tight collaboration with the company.
The aim of the project is to characterize the impact of Aβ and/or Tau pathology on synaptic function and structure using electrophysiology and two-photon imaging of biopsied human brain tissue obtained from idiopathic Normal pressure hydrocephalus (iNPH) patients, some of which have concomitant Alzheimer’s pathology. Early aims will be to set up electrophysiology protocols and assays to analyze intrinsic membrane properties and understand different neuronal response properties as a function of Alzheimer’s pathology. These experiments will be complemented with functional and structural imaging of synapses using genetically-encoded fluorescent reporters using two-photon microscopy.
A person to be appointed as a postdoctoral researcher shall hold a suitable doctoral degree. Positions of postdoctoral researchers shall always be filled for a fixed term (UEF University Regulations, Section 31).
The person to be appointed to the Postdoctoral Researcher Position is required to hold a doctoral degree, which may not have been completed more than five years ago at the time of accepting the position. In this context, the 5 years refer to a net period of time, which does not include maternity leaves, parental leaves, or military service, etc.
The language requirements associated with the position are defined in the Government Decree 770/2009. Members of the university’s teaching and research staff are required to have command of the language they give teaching in (Finnish or Swedish). The Dean of the faculty may grant an exemption from the language proficiency requirements laid down in the Government Decree.
The candidate should have a PhD in Neuroscience or a related discipline with experience in analyzing functional properties of neuronal circuits. Candidates with a PhD in physics or engineering and with sufficient background in Neuroscience are also encouraged to apply. Strong and proven experience in slice electrophysiology is desired. In addition, experience in immunohistochemistry, two-photon imaging, image and data analysis is advantageous. Enthusiasm and commitment will need to be coupled to attention to detail and strong analytical skills. Good knowledge of written and spoken English is essential. An ideal candidate must have a high degree of independent thought and initiative. The applicant needs to have recommendation from two previous and recent supervisors / PIs.
You will join a very active and well-equipped group of neuroscientists studying various aspects of neuronal function, neuroinflammation in the context of different neurological diseases. You will have a direct interaction with the experts in the neuroscience behind Alzheimer’s disease and therapeutics based at the company.
The position is filled for one year starting from 15.3.2018 or as agreed. The position is filled for a fixed term due to the duration of the project.
The salary of the position is determined in accordance with the salary system of Finnish universities and is based on level 5 of the job requirement level chart for teaching and research staff (€2,865.30/ month). In addition to the job requirement component, the salary includes a personal performance component, which may be a maximum of 46.3% of the job requirement component.
For further information on the position, please contact: Associate Professor Tarja Malm, tel: +358 40 3552209, tarja.malm@uef.fi. For further information on the application procedure, please contact: HR Secretary Asta Suhonen, tel. +358 40 3552000, asta.suhonen@uef.fi.
A probationary period is applied to all new members of the staff.
The electronic application should contain the following appendices:
– a résumé or CV
– a list of publications
– copies of the applicant’s academic degree certificates/ diplomas, and copies of certificates / diplomas relating to the applicant’s language proficiency, if not indicated in the academic degree certificates/diplomas
– Recommendation letters from two previous and recent supervisors / PIs.
The application needs to be submitted no later than 25.2.2018 (by 24.00 hours Finnish time) by using the electronic application form.
|
1.2.2018 | Ajankohtaista
The postdoc will be working with Kaisa Lehti, group leader at the Department of Microbiology, Tumor- and Cell biology (MTC) and Joseph Carlson, team leader in Oncology-Pathology and member of the group of Monica Nister. The expertise and background of these teams are complementary: Dr. Lehti’s group has extensive experience with cancer biology and translational studies within tumor biology. Dr. Carlson is a clinician scientist, who works in the Department of pathology, is responsible for the Gyn tumor biobank, Karolinska Hospital, and has a close working relationship with clinicians involved in ovarian cancer and sarcoma therapy. Thus the position includes excellent possibilities for translational (bench to bedside) research.
The tumors being investigated will be malignant sarcomas of the uterus (undifferentiated uterine sarcomas and uterine leiomyosarcomas) and high grade serous carcinoma of the ovary.
This position is an ideal opportunity for a recent graduate to learn new techniques and to work in an exciting translational research environment.
NOTE: The final application deadline is Feb 10!
1.2.2018 | Ajankohtaista
Senior Researcher in Breast Cancer Phosphoproteogenomics at the Centre for Biotechnology, University of Turku, Finland
Position for PhD (or soon-to-be) is available in the laboratory of Professor Jukka Westermarck at the Centre for Biotechnology, University of Turku, Finland (https://www.btk.fi/research/cancer-cell-signaling/). We are looking for a highly-motivated researcher to join our dynamic research group broadly focused on phosphoproteome signalling in human cancers.
Recent very rapidly accumulating data from others and us indicate that breast cancer progression and therapy responses are critically regulated at the phosphoproteome level, and that combination of genomic and phosphoproteome information (phosphoproteogenomics) may lead to better patient stratification strategies. The project is funded by Breast Cancer Now ([http://www.breastcancernow.org)]www.breastcancernow.org) and is focused on characterization of phosphoproteogenomics of human breast cancer cells, and on use of that information for prediction of breast cancer patient therapy responses. The project involves very close collaboration with strong bioinformatics, drug screening and breast cancer tissue explant teams with a common goal to advance the acquired information to future clinical practice.
Turku Centre for Biotechnology (TCB), University of Turku and Åbo Akademi University, is a top-quality research center harbouring several research groups with distinguished publication profile (http://www.btk.fi/). The centre harbours excellent core facilities including state-of-art proteomics facility (https://www.btk.fi/proteomics/). Furthermore, BioCity Turku umbrella organization offers very high-quality research training including e.g. frequent seminars by world recognized speakers.
Candidate requirements:
· PhD (already obtained or soon-to-be)
· At least one first author publication in a relevant journal
· Highly motivated person with strong interest in translational cancer research
· Hands-on experience in LC-MS proteomics, and especially phosphoproteomics analysis will be a clear asset
Our selected recent publications:
Wang et al., EMBO Reports, 2017
Kaur et al., Cancer Research, 2016
Kauko et al., Sci. Rep., 2015
Myant et al., Cell Reports, 2015
Laine et al., Cancer Discovery, 2013
More detailed information about the position (ID 4958), and instructions how to apply, can be found at:
http://www.utu.fi/en/university/come-work-with-us/open-vacancies/Pages/home.aspx
The DL for applications is the 5th of February, 2018.
27.1.2018 | Ajankohtaista
R&D Laboratory Technician – Thermo Fisher Scientific, Vantaa
Job Description
As the world’s leader in serving science, Thermo Fisher Scientific is a driving force in the research, healthcare, industrial and applied markets, generating more than USD 17 billion in annual revenue. No other company can match our range of customer touch points – technologically, geographically or commercially. We help our customers in finding cures for cancer, protecting the environment, making sure our food is safe and moving forward with thousands of important projects that improve millions of lives. At Thermo Fisher Scientific, each one of our 50,000 extraordinary minds has a unique story to tell. Join us and contribute to our singular mission—enabling our customers to make the world healthier, cleaner and safer.
In Finland we have over 700 employees in Vantaa and Joensuu. Our extensive range of products developed and manufactured in Finland includes pipettes, microplate instruments, magnetic particle processing systems as well as clinical chemistry and industrial chemistry analyzers and laboratory automation solutions. The Vantaa facility houses several different functions such as R&D, marketing, sales, service, logistics, quality as well as instrument and reagent manufacturing and is located close to the Vantaankoski railway station.
R&D Laboratory Technician
Vantaa, Finland
Thermo Fisher Scientific is currently recruiting for a R&D Laboratory Technician to our Microbiology Division (MBD) R&D team. The position is for a fixed term maternity leave cover starting in March 2018 and ending in January 2019.
We are looking for a proactive, self driven, result oriented team player. You enjoy working with high technology products. You want to develop yourself and the way of working. We offer motivating tasks in innovative working environment.
Key Responsibilities
- Early-stage research on Real Time PCR reagents to be used in microbiology diagnostics.
- Executing R&D projects in accordance with agreed plans and schedules
- Carrying out basic microbiological techniques (e.g. bacterial cultivations and enumeration) as well as food safety related techniques like sample enrichment and sample preparation methods
- Analyzing, concluding and reporting results to the local R&D team and give project updates
- Management of laboratory reagents (ordering and book keeping) and responsible for the operation and maintenance of laboratory instrumentation
Experience/Qualifications/Qualities
- Few years relevant research experience, preferably from molecular biology, microbiology etc.
- Knowledge of Real Time PCR and enzyme technology
- Knowledge of next generation sequencing technology is preferred
- Knowledge of scientific instrumentation and various software applications related to molecular biology; experience on instrumentation or software development strongly preferred
- Polytechnic degree in a Biochemistry, Molecular Biology, or Engineering discipline
- Demonstrated ability to execute systematic project work
- Ability and willingness to think through issues related to projects
- Time-management and organization skills to handle workload and meet timelines
- Sufficient computer skills and experience in MS Office package
- Good written communication skills in Finnish and English
- Strong communication and inter-personal skills
We look forward to receiving your application, including a cover letter and CV and a salary request in English. Please apply via http://jobs.thermofisher.com/. Reference: 61018BR. Please apply by the 7th of February, 2018.
If you have questions about Thermo Fisher Scientific and/or the position – please contact Senior R&D Scientist, Mikko Kauppinen, tel. +358 44 339 0129 on February 1st, 2018 between 12-14.
At Thermo Fisher Scientific, each one of our 50,000 extraordinary minds has a unique story to tell. Join us and contribute to our singular mission – enabling our customers to make the world healthier, cleaner and safer.
Thermo Fisher Scientific is an EEO/Affirmative Action Employer and does not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other legally protected status.
26.1.2018 | Ajankohtaista
Welcome to the Annual Meeting of the Finnish Connective Tissue Society (Sidekudostutkijat ry), which will be held on Friday February 9th, 2018 at 12-19 pm in Helsinki (Tieteiden talo, luentosali 104, os. Kirkkokatu 6). After the annual meeting, there is scientific program and a light dinner.
Registration by January 31st by e-mail to Piia Takabe (Piia.Takabe@uef.fi)
(including information of special diets).
Admission to the meeting is free!
Welcome!
Sanna Pasonen-Seppänen & Piia Takabe
26.1.2018 | Ajankohtaista
20 uutta terveysteknologian asiantuntijaa – Saranen Consulting
Alkuperäinen julkaisupäivä 11.1.2018
Kiinnostaako sinua ura vahvasti kasvavalla, kehittyvällä ja kansainvälisesti merkittävällä terveysteknologia-alalla? Haluatko tehdä merkityksellistä työtä ja olla mukana rakentamassa ratkaisuja ihmisten terveyden ja hyvinvoinnin edistämiseksi?
Sinustako terveysteknologian asiantuntija?
Etsimme motivoituneita ja kehittymishaluisia henkilöitä, jotka haluavat tulevaisuudessa työskennellä terveysteknologian kehittämisen parissa. Ohjelman avulla voit ottaa uuden suunnan työurallesi mielenkiintoisella toimialalla tai edetä seuraavalle tasolle asiantuntijatehtävissä – avoinna olevia tehtäviä on useita ja eritasoisia. HealthTechPro RekryKoulutus soveltuu niin vastavalmistuneelle ja uransa alussa olevalle osaajalle kuin kokeneelle ammattilaisellekin, joka haluaa laajentaa osaamistaan ja löytää uuden polun uralleen. Tärkeintä on motivaatiosi kehittää osaamistasi ja kiinnostuksesi terveysteknologia-alaa kohtaan.
Löytyykö sinulta taustaa tai kokemusta työn, opintojen tai harrastuneisuuden kautta esimerkiksi seuraavista:
- bioinformatiikasta ja luonnontieteistä
- hoitotyöstä
- tuotekehityksestä, tutkimus- tai laboratoriotyöstä
- projektitehtävistä
- ICT-alasta ja esim. ohjelmistokehityksestä
- myynnistä ja markkinoinnista
- ostoista- ja hankinnoista
- laitehuollosta
- laadunhallinnasta ja -varmistuksesta
- sähkö-, mekaniikka-, tai elektroniikkasuunnittelusta tai
- terveysteknologiaan liittyvistä tehtävistä.
HealthTechPro Rekrykoulutus on suunniteltu sinulle, joka olet tällä hetkellä työtön, työttömyysuhan alainen tai lomautettuna. Voit hakea ohjelmaan myös, mikäli määräaikainen työsuhteesi on päättymässä ennen ohjelman alkua.
Rekrytoivat yritykset
Uusia osaajia hakevat useat eturivin terveysteknologia-alan yritykset, joiden tavoitteena on rekrytoida sinut työsuhteeseen ohjelman päätteeksi. Mukana rekrytoimassa ovat mm. Buddy Healthcare, Finnish Net Solutions, Heltti, Innokas Medical, Nightingale Health ja Agfa HealthCare. Tutustu rekrytoiviin yrityksiin ja työtehtäviin osoitteessa www.saranen.fi/healthtechpro.
Tavoitteemme on löytää sinun taustaasi, osaamiseesi ja mielenkiintoosi sopivin työnantajayritys ja työtehtävä rekrytoivien yritysten joukosta. Kun uusi tuleva työnantajasi on löytynyt, solmimme yrityksen ja sinun kanssasi ensin koulutussopimuksen ohjelman ajaksi. Tavoitteena on työsopimus ohjelman päätyttyä.
Toimiva konsepti
HealthTechPro RekryKoulutuksessa yhdistyvät käytännön työtehtävät sekä ammatillista kehittymistäsi tukeva asiantuntijakoulutus. 6 kuukautta (12.3.-7.9.2018) kestävän ohjelman aikana työskentelet yhteistyöyrityksessä käytännön työtehtävissä ja projekteissa. Lisäksi saat reilun 20 päivän terveysteknologian asiantuntijakoulutuksen, joka mahdollistaa kehittymisesi alalle. Pääkouluttajana toimivat Healthtech Finlandin asiantuntijat.
Ohjelman toteutuksesta vastaa Saranen Consulting tiiviissä yhteistyössä Uudenmaan ELY-keskuksen, TE-palveluiden, rekrytoivien yritysten ja Healthtech Finlandin kanssa.
Hae heti!
Hakemus kannattaa jättää mahdollisimman pian, sillä haastattelu- ja valintaprosessit käynnistetään jo hakuaikana. Mitä aiemmin tiedämme sinusta, sitä paremmat mahdollisuudet meillä on löytää juuri sinulle sopiva yhteistyöyritys. Haku päättyy 25.1.2018.
- Jätä työhallinnon hakemus osoitteessa www.koulutukset.te-palvelut.fi (koulutusnumero 676644).
- Pyydämme myös täyttämään oman osaamisprofiilisi / CV:si Saranen Consultingille.
Osaamisprofiilin perusteella suoritamme esivalinnan ja se toimii käyntikorttinasi rekrytoivien yritysten suuntaan, joten täytäthän sen huolella. Pidän sinut tietoisina hakuprosessin etenemisestä.
Lisätietoja osoitteesta www.saranen.fi/healthtechpro ja ohjelman yhteyshenkilöiltä Saranen Consultingilla:
- Janette Uusitalo, p. 050 305 3520
- Tiina Mäkinen, p. 040 762 9644
Tule kuulemaan lisää hakijainfoon ti 23.1.2018 klo 13. Info pidetään Saranen Consultingin tiloissa (Tekniikantie 12, Espoo, Innopoli 1 A, 3.krs).
Avainsanat: tuotepäällikkö, projektipäällikkö, tutkimus, insinööri, huoltoteknikko, koordinaattori, asiakkuuspäällikkö, data-analyytikko
25.1.2018 | Ajankohtaista
Senior Scientist, Industrial Enzymes – MetGen, Turku
Job description
Job Summary:
We are looking for a full-time Senior Scientist to join our R&D team in industrial enzyme development projects.
Senior Scientist will
- provide technical leadership in enzymology and protein engineering, manage associate scientists and scientists, and lead projects that improve the performance of industrial enzymes
- create vision and strategy on how to discover, produce in a suitable host, with the state of the art genetic tools and with performing fermentation technology and downstream to succeed in the mission.
- contribute to the company’s intellectual property portfolio and scientific publications. Present at internal meetings, external conferences, and meetings with outside partners/collaborators
Skills and Requirements:
Ph.D. degree in biochemistry, molecular biology, or a related discipline with several years of industrial experience in engineering enzymes
Expertise in all experimental aspects of enzyme technologies, including enzyme discovery, protein library design and screening, enzyme kinetics, and enzyme assay development.
Experience in the use of bioinformatics methods, protein structural analysis or modeling.
In-depth understanding of strain development, focusing on industrially relevant bacterial and fungal strains.
Send your application by email to info@metgen.com
Deadline for application is 15th of February.
25.1.2018 | Ajankohtaista
Study Director Neuroscience – Charles River Laboratories, Kuopio
Job description
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work e perform. In return, we’ll help you build a career that you can feel passionate about.We are looking for scientist with proven track of experience in neuroscience to join Charles River Discovery Research Service site located in Kuopio, Finland.In this position you are responsible to lead Client projects in CNS drug discovery field. The Study Director will ensure the scientific excellence of study design, execution, data analysis and reporting. The Study Director will lead execution of the projects working closely with the team. The responsibilities of this position include communication with the Clients as needed in all phases of the projects. The position require an expertise in in vivo animal models of CNS diseases, as well as capabilities to set up and develop new techniques and participate in R&D projects. The Study Director will provide scientific input and assist in preparation of marketing materials.
Qualifications
- Higher education degree in biological science (MSc, MD), preferably PhD degree
- At least 2 years of experience with CNS in vivo work, including independent project execution and preferably project supervision
- Understanding of scientific studies experimental design, underlining scientific principles, and ability to analyze data and interpret results
- Understanding/practical experience with in vivo pharmacology
- Knowledge in CNS animal models (incl. surgery techniques) and related behavioral assays
- Fluent English oral and written
- Scientific writing ability
- Good problem solving skills, ability to coordinate and prioritize
- Excellent communication, interpersonal, and teamwork abilities
- Pharmaceutical industry or academic post-doctoral experience will be an asset
About Discovery
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.For more information, please visit www.criver.com.
Equal Employment Opportunity
Charles River Laboratories, Inc. is an Equal Opportunity Employer M/F/Disabled/Vet
